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ABSTRACT
Yersinia pestis, the causative agent of plague, secretes a set of virulence proteins called
Yops when in contact with eukaryotic cells. A subset of these Yops is translocated
directly into the cytosol of the host eukaryotic cells by the type III secretion system.
Using a protein tag-based reporter system, this study is focused on the translocation of
these Yops into the cytosol of canine derived cell lines: MDCK and DH82. The MDCK
cell line is a canine derived epithelial cell line, and the DH82 cell line is a canine derived
monocyte cell line. The reporter system uses a phosphorylatable peptide tag, called the
Elk tag. Translocation of an Elk-tagged protein into eukaryotic cells results in host cell
protein kinase-dependent phosphorylation that can be detected by phosphospecific
antibodies. Canines are typically considered resistant to plague infections. Previous work
has shown the requirement of receptor FPR1 for Yops translocation into mouse and
human cells. Therefore, translocation of Yops into canine cells was examined because a
lack of Yops translocation could explain plague resistance in canines. The translocation
of Elk-tagged YopE was observed in the canine derived cell lines MDCK and DH82.
This data suggests that there may be an underlying immune response allowing canines
infected with Yersinia pestis to recover.
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CHAPTER 1
INTRODUCTION
History of Plague
Yersinia pestis is the causative agent of the plague. This bacterium has been
responsible for millions of deaths worldwide over the ages (1). Y. pestis is responsible for
one of the earliest pandemics in the world. This pandemic would be the first of three
major plague pandemics to occur throughout history (2). The first plague pandemic was
referred to as the “Plague of Justinian,” or the Justinian plague (3). It got its name from
emperor Justinian who was ruler of the Byzantine empire in the sixth century when this
pandemic occurred (3). The outbreak is thought to have begun in Egypt, where it moved
along maritime trade routes to Constantinople (2). Once there, the infection killed
thousands of residents. It is said that there were so many dead that the authorities had
difficulties disposing of them. The people at the time believed that the plague was due to
the wrath of God against a world full of sin. However, modern day science concludes that
the bacterium was spread by infected domestic rats along trade routes (4).
The second, and most well-known, plague pandemic was the Black Death in
Europe during the 14th century (5). Plague infections accounted for the death of around
one-fourth of the entire population of Europe during the Black Death (2). For the next
three centuries, plague outbreaks occurred throughout Europe (3). In the 1700s accounts
of plague infections began to lessen, this is thought to be a result of progress in sanitation
1

and a change in domestic housing that excluded rats from human dwellings (6). However,
plague infections never fully went away, throughout the 1800s and early 1900s outbreaks
took place around the world (Fig 1).

Figure 1
Locations of plague outbreaks in the 1800s and early 1900s. Locations of major
plague outbreaks in the 1800s and early 1900s. Port cities became hubs for transmitting
plague infections around the world. Used with permission (35).

The third plague pandemic allowed for advancements to be made in the scientific
understanding of the disease (3). In the late 1800s, the germ theory of disease was
recognized as true based on the work of Louis Pasteur, Joseph Lister, and Robert Koch
(7). The third pandemic took place in the 1850s in the Yunnan province of southwestern
China and spread across the world through port towns into the early 1900s (2). During
this time, two scientists independently isolated the organism responsible for causing
2

plague (8). The bacteriologists, Alexandre Yersin and Kitasato Shibasaburo found
bacteria in fluid samples taken from plague victims and injected them into animals and
observed how the animals died quickly of plague. Yersin named the newly identified
bacterium Bacillus pestis (9). Over the turn of the century, the bacterium would go
through several name changes, from Bacillus pestis to Pasteurella pestis and finally to
Yersinia pestis in the mid-1900s in honor of Yersin himself (9).
Clinical presentation and Treatment
Plague infections do not all present themselves the same way; presentation of the
disease is dictated by what part of the body is infected and how long the host has been
infected (3). Naturally occurring plague infections are spread by flea-borne transmission
and usually exhibit the bubonic form of the disease (2). The bubonic plague is most
associated with swelling of the lymph nodes due to excessive bacterial proliferation. The
swollen lymph nodes, or buboes, seeping pus and bacteria can lead to other forms of the
disease as the bacteria spreads to other parts of the body (10). Without treatment there is
a 60% fatality rate from this type of plague infection, primarily through secondary sepsis
and other complications. Thirty percent of flea-borne plague infections manifest as
septicemic plague, a disease of the blood, without ever forming buboes. These infections
are more difficult to diagnose due to lack of symptoms until organ failure begins to occur
(10). Pneumonic plague is the most lethal form of the bacterial disease, with a nearly
100% fatality rate without treatment within 24 hours of onset of symptoms (11). Primary
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pneumonic plague infections can begin to display symptoms in as early as 24 hours after
initial exposure. Symptoms of pneumonic plague include fever, coughing, and difficulty
breathing; death occurs from respiratory failure or sepsis (12).
All three forms of plague infections have a marked absence or severely limited
immune response in the initial stages of infection. Yersinia pestis uses several different
methods to avoid the host immune system. This allows the bacterium to grow to an
extreme abundance, which can be seen in septicemic patients. It is thought that Yersinia
uses this avoidance strategy for propagation; after growing to high enough numbers the
bacteria can be effectively taken back into a flea vector through a blood meal (13). The
death of the human host also forces the flea vector to seek other hosts, which propagates
the bacterium (1).

4

Figure 2
Life cycle and transmission of plague infections. Fleas and rodents are natural
reservoirs of plague and can pass the infection to humans by direct contact. Humans once
infected, can transmit infections to other humans as bacterial infections progress without
treatment. Used with permission (36).

Unlike during the three major plague outbreaks throughout human history,
nowadays, plague infections can be treated with broad-spectrum antibiotics such as
tetracycline or streptomycin (14). Individuals infected with the bacterium should be
isolated and exposed individuals should be quarantined depending on the form of plague
infection (15). Modern plague infections, if treated early, can have a positive outcome.
However, there are no current approved vaccines against Yersinia pestis infections (16).

5

Yersinia pestis and Virulence Factors
Yersinia are gram-negative bacteria that belong to the Enterobacteriaceae family
(17). There are three human pathogens classified in the Yersinia genus: Y. pestis, Y.
enterocolitica, and Y. pseudotuberculosis (14). Of these three bacteria, Y. pestis causes
the most lethal disease manifestation, meanwhile Y. enterocolitica and Y.
pseudotuberculosis cause the gastrointestinal infection, yersiniosis (18). Y. pestis is
thought to have evolved from Y. pseudotuberculosis, which is closely related, as recently
as 1,500 to 20,000 years ago (19). Y. pestis is a non-motile, non-spore forming
coccobacillus (5). The bacteria display a bipolar staining with Giemsa, Wright’s, or
Waysin stain (5). Yersinia pestis can grow in a wide range of temperatures from 4˚C to
42˚C, however optimal growth is between 28˚C and 30˚C (20). Compared to E. coli, Y.
pestis growth is slow, requiring 24 to 48 hours for colony formation on rich media. The
generation time in defined media can be as short as 1.25 hours (15).
Yersinia pestis has been grouped into three biovars, which are variants that differ
either physiologically or biochemically. In the instance of Y. pestis, the biovars are
determined by the bacteria’s ability to convert nitrate to nitrite and the fermentation of
glycerol (21). Biovar Antiqua has been associated with the first major plague pandemic
and can reduce nitrate to nitrite and ferment glycerol (15). Medievalis was the biovar
associated with the Black Death plague and does not have the ability to reduce nitrate but
could ferment glycerol (15). The third plague pandemic was associated with the biovar,
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Orientalis, which could reduce nitrate to nitrite but could not ferment glycerol (15).
However, recent analysis of samples from plague victims indicates that all three
pandemics were linked to the Orientalis biovar (21). The KIM strain, Kurdistani Iraqi
Man, or better referred to as the wild-type strain in this manuscript is of the Medievalis
biovar (22).
Bacteria such as Y. pestis have evolved efficient strategies to negate host defense
systems that allow the bacteria to invade, colonize, and multiply is host tissues (14).
Yersinia pestis has also acquired a mechanism to survive inside the mid-gut of fleas when
evolving from Y. pseudotuberculosis (23). The KIM strain of Y. pestis contains three
plasmids: pPCP1 (encodes for pesticin, coagulase, plasminogen activator), pMT1
(encodes for murine toxin), and pCD1 (encodes for the T3SS) (15). The pMT1 plasmid
encodes the murine toxin which is toxic to mice and rats, but not to dogs or rabbits (15).
The murine toxin is part of the phospholipase D family that functions to block the flea gut
from killing the bacterium during the vector stage of the Y. pestis life cycle (21). This is
one of the reasons proposed to play a role in the bacteria’s survival in the flea. The pgm
(pigmentation) locus is a chromosomally located region that contains the hms (hemin
storage) locus, which is responsible for blocking the flea mid-gut and allowing the
bacteria’s survival (15). The pgm locus also contains the yersiniabactin (Ybt) system
which participates in iron acquisition (18). Iron is an essential micronutrient in
mammalian proteins that is chelated to prevent the iron from being used by pathogens.
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Yersinia pestis uses yersiniabactin to acquire iron and survive in the iron restricted
environment in the host (24).
Once established inside the host, Y. pestis can avoid host immune defenses and
spread to the draining lymph nodes (25). Expression of the plasminogen activator protein
(Pla), which is encoded in the pPCP1 plasmid, is required for the dissemination of the
bacteria from the site of a flea bite (18). Another important mechanism Y. pestis employs
is the expression of the F1 capsule at 37˚C from the pMT1 plasmid (14). The F1 capsule
forms an envelope around the bacteria that enable it to resist phagocytosis (18). The
bacterium also possesses a type III secretion system that is used to deliver antiphagocytic effector proteins into host cells (26).
Type III Secretion Systems
The type III secretion system (T3SS) is a protein-secretion machine used by many
gram-negative bacteria to deliver virulence factors into eukaryotic host cells (26). The
effectors that bacteria secrete into the host cell are specific to that pathogen, however, the
T3SS is used in all cases to contribute to infection of the eukaryotic cell and allows the
bacteria to communicate with the host cell (27). In the instance of Y. pestis, the effectors
block phagocytosis by macrophages, suppress the production of pro-inflammatory
cytokines, and disturb the dynamics of the host cytoskeleton (28). These traits allow for
the survival and replication of the bacteria in lymphoid tissues (28).
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The machinery is made up of a basal body that spans both bacterial membranes
and an extracellular needle that protrudes from the bacterial surface (26). The T3SS is not
constantly active, this mechanism is activated upon physical contact with a eukaryotic
cell (29). Once contact with the host cell is achieved the bacterium will secrete two
classes of proteins (28). The first being translocator proteins, YopB and YopD, which
form a translocation pore on the surface of the host cell. The needle-cap protein, LcrV,
binds to this translocation pore and allows for effector proteins to be translocated into the
cytosol of the eukaryotic host (28). The type III secretion system exists to modulate host
cell signaling in ways that benefit the bacteria (38). This task is completed through the
translocation of “toxic” effectors called Yops (Yersinia outer proteins) from the
bacterium into the eukaryotic host (38). Each Yop performs a specific task in the
overarching goal of hijacking the host intercellular signaling (39).
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Figure 3
Key features of the type III secretion system needle-protein complex. A model
showing the structural components of the type III secretion system needle-protein and
how that needle-protein binds to the surface of a host cell and allows for Yop
translocation. Used with permission (37).

Canine Immunity and Why Dogs Matter
Plague infections do not occur in all mammals. Unlike humans, rabbits, and
rodents, canines such as wolves, dogs, coyotes, and foxes, are considered resistant to
plague infections (40). Canines typically are not found to be infected by the plague
because they display little to no symptoms even when they are infected (40). Canines also
can recover from plague infections in the few instances when they become infected (40).
10

This plague resistance is hypothesized to manifest because canines have lost Fpr1 and the
ability to respond to N-formylpeptides. Canines instead have a duplicated Fpr2 gene (41).
In humans and mice, Fpr1 is the gene that encodes N-formylpeptide receptor that
is essential for the needle cap protein, LcrV, of the T3SS to bind to the surface of a host
cell and is considered a plague receptor (41). Previous work has shown mice that are
Fpr1-deficient have increased survival rates and a protective immune response against
Yersinia pestis (41). Fpr1 has been co-purified with the Y. pestis proteins LcrV and YopD
that are responsible for the binding of the T3SS needle to the surface of a eukaryotic cell
(41). This demonstrates an interaction between Fpr1 and the T3SS needle. The lack of
Fpr1 in canines, which express Fpr2, could be responsible for their plague resistance,
unlike their human counterparts with Fpr1 (41). Multiple sequence analysis of the human
Fpr1, human Fpr2, and the canine Fpr2 proteins identify several differences in amino acid
expression amongst the three proteins. There are approximately thirty non-conservative
mutations between the three receptor proteins (Fig 4). These amino acid differences could
explain canine plague resistance.
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Figure 4
Multiple Sequence Analysis of Human Fpr1, Human Fpr2, and Canine Fpr2. All
three sequences were taken from NIH BLAST and compared using the EMBOSS Cons
program on the EMBL-EBI website. NP_001180235.1 is the sequence for human Fpr1.
NP_001005738.1 is the sequence for human Fpr2. XP_005616269.1 is the sequence for
canine Fpr2.

Although canines do not commonly become infected by plague, they can serve as
a sentinel species in high-risk areas (42). Canines in high-risk areas such as Madagascar
typically are free-range working dogs (40). These dogs are susceptible to two main types
of exposures to plague infections. One such exposure is a dog consuming rodents infected
with Yersinia pestis (40). The other would be a dog being bitten directly by an infected
12

flea (40). Typically rat populations are monitored in areas where plague infections are
possible. However, by the time researchers can identify a shrinking rat population due to
infection deaths, exposures and infections may already be circulating through the
population (40). This is where dogs and other canines can be an incredibly useful tool in
monitoring plague outbreaks. The dogs that already are near humans in these high-risk
areas could be monitored for infections (42). By monitoring the canine population in
conjunction to the rat populations, scientists may identify outbreaks before they become
an issue for the human population (42).
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CHAPTER II
MATERIALS AND METHODS
Bacterial strains, culture conditions, and plasmids
The Y. pestis and Escherichia coli strains used in this study are listed in Table 1.
All bacterial strains were stored at -80°C in 50% (v/v) glycerol. E. coli strains were
grown at 37°C in Luria-Bertani (LB) broth (Difco, Thermo Fisher Scientific, Waltham
MA) or on tryptose blood agar (TBA, Difco, Thermo Fisher Scientific, Waltham MA)
plates. Y. pestis strains were grown at 26°C on TBA plates or in TMH medium (33). TBA
plates contained antibiotics as needed. Streptomycin and ampicillin were used at a
concentration of (100 µg/ml). Plasmids used in this study are listed in Table 1. Plasmid
DNA was isolated using a QiaPrep Spin kit (Qiagen, Inc, Studio City, Calif.). Cloning
methods were as described previously (43). Electroporation of DNA into Y. pestis was
done as described previously (44).
Table 1: Strains and plasmids used in this study
Strain
Relevant properties
reference
E. coli
BRL
D27XSm
D27XSm ∆yopB
Plasmids
pYopE-Elk
p141 CB

Source or

Host used in plasmid cloning

Gibco-

Yersinia pestis attenuated wild type
Yersinia pestis YopB mutant

(30)
(32)

Encodes YopE-Elk chimera, Apr
araBAD promoter fused to yopE-Elk1, Apr

(45)
(32)
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Eukaryotic cell lines, culture conditions
The eukaryotic cell lines used in this study are listed in Table 2. The cell lines
HeLa, MDCK, and DH82 were maintained in DMEM (Corning, Manassas, VA)
supplemented with Penicillin/Streptomycin (Gibco, Life Technologies), non-essential
amino acids (Gibco, Life Technologies), 25 mM Hepes buffer (Gibco, Life
Technologies), and BSA 7.5% (Gibco, Life Technologies). The cell lines HeLa and
MDCK were supplemented with 5% (v/v) heat-inactivated fetal bovine serum (FBS,
Gibco, Life Technologies). The DH82 cell line was supplemented with 15% (v/v) heat
inactivated FBS. All eukaryotic cell lines were incubated at 37°C under a 5% CO2
atmosphere.
Table 2: Eukaryotic cell lines used in study
Strain
Relevant properties
reference
HeLa
CCL-2
MDCK
34
DH82
10389

Source or

Human derived epithelial cell

ATCC #CRM-

Canine derived epithelial cell

ATCC #CCL-

Canine derived monocyte cell

ATCC #CRL-

Infection assay
Prior to infection, eukaryotic cells were subcultured to a density of 2.5 x 105 cells
per well into 35-mm-diameter six-well tissue culture plates in DMEM-FBS at 37°C in a
5% CO2 atmosphere for 48 hours. The DH82 cells were activated with LPS (E. coli 026:
15

B6, Millipore Sigma) at a concentration of 100 ng/ml 24 hours prior to infection. Cells
were washed twice with warmed L15 (Corning, Manassas, VA) media lacking FBS
immediately prior to infection. Y. pestis was cultivated at 26°C in TMH media overnight
prior to infection. The optical density at 620 nm (A620) of the bacterial strains were
measured and Y. pestis strains were added directly to wells containing L15 medium and
eukaryotic cells to a multiplicity of infection (MOI) of fifteen. 1 A620•ml of Y. pestis is 3
x 108 bacteria/ml. Plates were then allowed to incubate at 37°C with humidification for 4
hours. After incubation, each well was photographed using light microscopy with 20x
magnification using Hoffman modulation contrast. After infection, each well was washed
twice with cold PBS. 10 µl Protease inhibitor cocktail (Sigma-Aldrich #P8340) and 10 µl
phosphatase inhibitor cocktail (Sigma-Aldrich #P2850) were added to each well. 2X
Laemmli sample buffer was added to each well to lyse cells (46). Sample buffer added
was adjusted so samples represented equivalent amounts of the original bacterial cultures
(0.01 OD620•ml/µl). Cells were scraped off the surface of plate and added to 1.5ml
microfuge tubes. Samples were boiled for 5 minutes, vortexed to shear DNA, and
centrifuged for 10 minutes at 10,000 x g before being analyzed by SDS-PAGE and
immunoblotting.
Protein electrophoresis and immunodetection
Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDSPAGE), using 15% (wt/vol) polyacrylamide gels (Bio-Rad, Hercules, CA) as indicated,
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according to the method described by Laemmli (46). Samples were loaded such that lanes
containing different culture fractions represented equivalent amounts of the original
bacterial cultures (0.05 OD620•ml/well). Proteins separated by SDS-PAGE were
transferred to Immobilon-P membranes (Millipore Corp., Bedford, Mass.), using transfer
buffer (47). Specific proteins (Elk-1, Phospho-Elk-1, and YopE) were visualized on the
membranes by using the following rabbit polyclonal antibodies specific for the proteins at
the indicated dilutions: Elk-1 antibody (1:1000; Cell Signaling #9182), Phospho-Elk-1
antibody (1:1000; Cell Signaling #9181), and YopE antibody (1:20,000; ). Bound
primary antibodies were detected with alkaline phosphatase conjugated to secondary
antibodies (goat anti-rabbit immunoglobulin G; 1:2,000; Cell Signaling #7054) followed
by color development with 5-bromo-4-chloro-3-indolylphosphate–nitroblue tetrazolium
(NBT-BCIP) (Thermo Fisher Scientific, Chicago, IL).
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CHAPTER III
RESULTS
Yersinia pestis induces MDCK and DH82 cell cytotoxicity.
The epithelial cell line, HeLa, has been characterized to display a “rounding up”
effect when exposed to Yersinia pestis (34). For the sake of these experiments this change
in the eukaryotic cell morphology was a positive control when analyzing the MDCK and
DH82 cell lines. HeLa cells were infected to an MOI of 15 and contact time with the
bacterium was allowed for 4 hours. As has been previously studied, HeLa cells infected
with the wild-type strain of Y. pestis displayed a “rounding up” effect (Fig 5). A deletion
mutant of the wild-type strain of Y. pestis was used as a negative control for this
“rounding up” effect. This strain had the inability to produce YopB, which is a necessary
protein for the binding of the T3SS apparatus to the surface of a eukaryotic cell (32).
Thus, when eukaryotic cells are infected with this strain of Yersinia cannot be intoxicated
by translocation of Yops into the cytosol of the cell (Fig 5).
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Figure 5
HeLa cell infections by Yersinia pestis wild-type strain and YopB mutant. HeLa cells
were infected at an MOI of 15. Images were captured 4 hours post infection on an
Olympus IX50 inverted microscope fitted with a Nikon D70 digital camera
(magnification 200x) to document cell cytotoxicity. These images are representative of
repeated experiments.

The MDCK cell line was infected with the same two strains of Y. pestis, a wildtype strain and the YopB mutant (Fig 6). The MDCK cells infected with the wild-type
strain of Yersinia displayed the same “rounding” effect as infected HeLa cells (Fig 6).
Alternatively, the MDCK cells that were exposed to the Y. pestis YopB mutant did not
19

experience a change in morphology (Fig 6). The DH82 cell line displays a mixed
morphology of cell types, both rounded cells and skinny-irregular shaped cells, under
normal growing conditions. When exposed to Yersinia pestis the DH82 cell lines behave
similarly to the MDCK cell line (Fig 7). The wild-type exposed DH82 cells lost the
morphology of skinny-irregular shaped cells, all DH82 cells became rounded after 4
hours of exposure (Fig 7). The DH82 cells that were exposed to the YopB mutant did not
experience a change in morphology compared to normal growing conditions (Fig 7).
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Figure 6
MDCK cell infections by Yersinia pestis wild-type strain and YopB mutant. MDCK
cells were infected at an MOI of 15. Images were captured 4 hours post infection on an
Olympus IX50 inverted microscope fitted with a Nikon D70 digital camera
(magnification 200x) to document cell cytotoxicity. These images are representative of
repeated experiments.
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Figure 7
DH82 cell infections by Yersinia pestis wild-type strain and YopB mutant. DH82
cells were infected at an MOI of 15. Images were captured 4 hours post infection on an
Olympus IX50 inverted microscope fitted with a Nikon D70 digital camera
(magnification 200x) to document cell cytotoxicity. These images are representative of
repeated experiments.

Yersinia pestis translocates Yops into the cytosol of MDCK and DH82 cells.
Yersinia pestis can translocate Yops into the cytosol of HeLa cells, which is
indicated by the rounding of HeLa cells after being exposed to the bacterium. Logically,
we wanted to analyze the cytosol of the eukaryotic cells to confirm Yop translocation.
22

This was done by electroporating a plasmid containing an Elk tag, which can be
phosphorylated inside eukaryotic cells, into the Y. pestis strains of interest. The wild-type
strain of Yersinia was transformed with a plasmid that encoded the YopE-Elk-1 chimera
under control the native yopE promoter. The YopB mutant strain was transformed with a
plasmid that encodes the YopE-Elk-1 chimera controlled by the arabinose inducible
araBADp promotor. This plasmid would prevent the bacteria from intoxicating eukaryotic
cells unless arabinose was present in the cell culture media. Phosphorylation of the
YopE-Elk-1 chimera would allow us to know if Yops from Y. pestis were entering the
cytosol of the eukaryotic cells. In this way, analyzing the immunoblots were quite
straight-forward. The Elk tag from the plasmid can only be phosphorylated by eukaryotic
cell-specific protein kinases. A band on the immunoblot probed with the Elk-1-PO4
specific antibody would indicate that Yops did enter the eukaryotic cell through
translocation.
Once again, the HeLa cell line would be used as a control for the two canine cell
lines, MDCK and DH82. As expected, the uninfected HeLa cells showed no signs of
Yops from Yersinia pestis (Fig 8a, 8b, 8c). The HeLa cells infected with the wild-type
strain of Yersinia displayed Yop expression for all three proteins assessed: YopE-Elk-1,
phosphoYopE-Elk-1, and YopE (Fig 8a, 8b, 8c) and translocation of YopE-Elk-1 was
detected by the presence of phospho-YopE-Elk-1 (Fig 8b). The HeLa cells that were
infected with the YopB mutant of Y. pestis expressed YopE and YopE-Elk-1 (Fig 8a and
8c) while no expression of phospho-Elk-1 (Fig 8b) was detected. Yop translocation into
23

the MDCK cell line was expected because the MDCK cells behaved similarly to the
HeLa cells when looking at the cell cytotoxicity. When looking at the YopE antibody blot
(Fig 8c), the MDCK cells infected with the wild-type strain of Y. pestis showed there was
YopE-Elk-1 expression in the cell. However, the MDCK cells infected with the YopB
mutant strain did not experience any Yop expression (Fig 8c). This trend continued for
the MDCK cells with both the Elk-1 antibody and the phospho-Elk antibody (Fig 8a, 8b).
In both instances the MDCK cells displayed Yop expression with the wild-type strain of
Yersinia but did not display Yop expression with the YopB mutant. The DH82 cell line
also was probed with these three antibodies: YopE, Elk-1, and phospho-Elk. The DH82
cells that were infected with the YopB mutant of pestis did not experience Yop
expression (Fig 8a, 8b, 8c). Yop translocation and expression was noted in the DH82
cells that were infected with the wild-type strain of Yersinia pestis (Fig 8a, 8b, 8c).

24

A. α-Elk-1

B. α-phospho-Elk

C. α-YopE

Figure 8
Expression and translocation of YopE-Elk in HeLa, MDCK, and DH82 cells.
Translocation and phosphorylation of YopE-Elk in infected HeLa, MDCK, and DH82
cells. Proteins were analyzed by probing with α-Elk-1, α-phospho-Elk, and α-YopE
primary antibodies. Proteins were visualized by probing with alkaline phosphatase
conjugated antibodies and developed with NBT-BCIP.
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CHAPTER IV
DISCUSSION
Yop translocation occurs in MDCK and DH82 cells
In this study, we evaluated the hypothesis that MDCK and DH82 cells can be
infected by Yersinia pestis. We compared Yop translocation in the human epithelial cell
line, HeLa, to the canine derived cell lines MDCK and DH82. As can be seen in Figure 6,
the MDCK cells exhibit the same cell cytotoxicity as HeLa cells when exposed to the
bacterium Y. pestis. Figure 7 displays this same cell cytotoxicity in the DH82 cells. This
change in cell cytotoxicity has been used previously as an identifier of Yop translocation
in HeLa cell studies (34). In that same way, the cell lines MDCK and DH82 can be
considered to experience Yop translocation into the cytosol. Yop translocation can be
confirmed through the immunoblot analysis. The phosphorylatable Elk-tag that was
expressed by Yersinia pestis was used to identify the presence of the YopE-Elk-1 chimera
in the cytosol of the canine cells. The detection of phosphorylated YopE-Elk-1
demonstrates translocation of Yops (45). The blots that were probed α-phospho-Elk (Fig
8b) show that YopE-Elk-1 chimera entered the cytosol of the eukaryotic cells. This
YopE-Elk conjugate can only be phosphorylated by cell specific protein kinases inside
the host cell. The α-YopE blots were probing directly for the protein YopE (8c). The
eukaryotic cells infected with the wild-type strain of Y. pestis were positive for both
bands that were expected being probed with this antibody. The lighter, top band is YopE
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and the dark and lower band represents the Elk-tagged YopE. Although bands on
different gels cannot be directly compared, the main purpose of this series of experiments
was to determine whether Yops can be translocated into the cytosol of the canine derived
cell lines. The samples added to each lane for the immunoblots were normalized using
the same number of bacteria (using A620•ml of bacteria as a surrogate for bacterial
numbers) added to the eukaryotic cells during infection.
Moving forward, the DH82s hold the key
Previously, the canine’s ability to be plague resistant was postulated to the
absence of the protein Fpr1 (41). However, the data collected in these experiments
indicate the canine derived cell lines MDCK and DH82 can be infected by Yersinia pestis
and experience Yop translocation. Knowing that canine cells can be intoxicated by the
bacterium, several key points come to mind. First involving canines expressing the
protein Fpr2 which is different than the human expressed Fpr1 and Fpr2. Multiple
comparison analysis of the three protein amino acid sequences shows there are nonconserved regions which differ between the human and canine proteins. These amino
acid differences could contribute to an overall structure and function change of the
protein. Further analysis of the association found between human Fpr1 and LcrV should
be completed.
Canines infected by Y. pestis typically display little symptoms or are completely
asymptomatic. This brings to question the possibility of an innate immune response that
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canines have to be able to fight off plague infection. This is where the DH82 cell line
becomes important. The DH82 cells are a monocyte cell line that were activated into
macrophages for the purpose of these experiments using LPS. Macrophages are used by
the host cell to eliminate foreign pathogens through phagocytosis. The next logical step in
this research is to look at whether the DH82s are being infected by Y. pestis or if the
DH82 cells are ingesting Y. pestis by phagocytosis. This could be examined using a
gentamicin protection assay, a standard assay to detect intracellular bacteria. The assay
would compare the DH82 cell line to a human derived monocyte cell line, THP-1, human
and murine macrophages are not infected by Y. pestis or taken up by phagocytosis to any
significant degree as the bacteria remains extracellular. Gentamicin is an antibiotic that
does not have the ability to enter the eukaryotic cell. The assay can be used to
differentiate between bacteria that are in the cytosol of a host cell and those that remain
extracellular. This would help to shed a light on whether the DH82 cells are being
infected by the bacteria or are undergoing phagocytosis of the invading bacteria. An
assay blocking phagocytosis in the macrophages, by disrupting actin using cytochalasin
D, would aid in determining whether the DH82 cells are truly infected by Y. pestis or if
DH82 cells can phagocytose Y. pestis.
If there is an activation of the innate immune system when canines are exposed to
Yersinia pestis, running flow cytometry to determine which macrophage types are being
induced would provide vital information. M1 and M2 macrophages are activated by
different cytokines and are associated with two different activities in cells. M1
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macrophages inhibit cell proliferation and cause tissue damage to the surrounding cells,
while M2 activity promotes cell proliferation and tissue repair. Understanding which
subtype of macrophage is being activated in infected DH82 cells can give key insights
into how canines can recover from Y. pestis infections.
Canines in locations where plague outbreaks may occur can serve as a sentinel
species for identifying outbreaks before they occur. The more we understand how canines
are able to fight off a pathogen seemingly perfect at evading host immune responses, the
closer we become to applying the knowledge towards human use. These experiments
took a step towards understanding what makes canines different than humans when it
comes to Y. pestis infections. Not only do plague infections still occur around the world,
but the bacterium is considered a dangerous bioweapon. Understanding how infections
are overcome in key groups could be the difference in protecting people from further
harm from this famous pathogen.
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